0001236031-19-000014.txt : 20190412
0001236031-19-000014.hdr.sgml : 20190412
20190412170324
ACCESSION NUMBER: 0001236031-19-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190411
FILED AS OF DATE: 20190412
DATE AS OF CHANGE: 20190412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watson Robert Eugene
CENTRAL INDEX KEY: 0001511858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 19746949
MAIL ADDRESS:
STREET 1: 245 N. HIGHLAND AVE NE
STREET 2: SUITE 230-296
CITY: ATLANTA
STATE: 2Q
ZIP: 30307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-04-11
0
0000725363
CEL SCI CORP
CVM
0001511858
Watson Robert Eugene
245 N. HIGHLAND AVE NE
SUITE 230-296
ATLANTA
2Q
30307
GEORGIA
1
0
0
0
Options
5.65
2019-04-11
4
A
0
160000
0.01
A
2029-04-10
Common Stock
160000
250000
D
The stock options vest in three (3) equal annual installments commencing one year after the grant date.
Robert Watson
2019-04-12